Corticobasal Degeneration Clinical Trials

7 recruiting

Frequently Asked Questions

Common questions about Corticobasal Degeneration clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

The CurePSP Genetics Program

PSPPSP - Progressive Supranuclear PalsyCorticobasal Syndrome+4 more
Massachusetts General Hospital1,000 enrolled1 locationNCT06647641
Recruiting

Gait Analysis in Neurological Disease

Multiple System AtrophyHuntington DiseaseCorticobasal Degeneration+5 more
Beth Israel Deaconess Medical Center120 enrolled1 locationNCT02994719
Recruiting
Not Applicable

The Swedish BioFINDER 2 Study

DementiaMultiple System AtrophyAlzheimer Disease+9 more
Skane University Hospital1,505 enrolled2 locationsNCT03174938
Recruiting

AI-Enhanced Optimization of Acute Levodopa Challenge Test

Corticobasal Degeneration (CBD)Progressive Supranuclear Palsy (PSP)Parkinson Disease (PD)+4 more
Beijing Tiantan Hospital2,000 enrolled1 locationNCT06949865
Recruiting

NYSCF Scientific Discovery Biobank

Ovarian CancerCervical CancerDiabetes Mellitus+26 more
New York Stem Cell Foundation Research Institute10,000 enrolled1 locationNCT06203106
Recruiting
Not Applicable

The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related Disorders

Multiple System AtrophyCorticobasal DegenerationDystonia+5 more
Queen Mary University of London70 enrolled1 locationNCT06174948
Recruiting

Neurodegenerative Diseases Progression Markers (MARKERS-NDD)

Cognitive ImpairmentDementiaMultiple System Atrophy+15 more
Casa di Cura San Raffaele Cassino600 enrolled1 locationNCT06596746
Recruiting

Modifiable Variables in Parkinsonism (MVP)

Corticobasal DegenerationDementia With Lewy BodiesProgressive Supranuclear Palsy+6 more
Bastyr University2,000 enrolled1 locationNCT02194816